Table 2. No-Show Rates in the Prepandemic and Pandemic Periods by Subspecialtya.
| Subspecialty | Rate of telehealth use during pandemic period, % (95% CI) | No-show rate, % (95% CI) | Unadjusted change in no-show rate (prepandemic to pandemic period) | Adjusted change in no-show rate (prepandemic to pandemic period) | |||
|---|---|---|---|---|---|---|---|
| Prepandemic period | Pandemic period | Difference (95% CI) | P value | Difference (95% CI) | P value | ||
| Lower telehealth use | |||||||
| Orthopedics | 5.7 (5.6 to 5.8) | 7.9 (7.8 to 8.1) | 7.5 (7.3 to 7.7) | NA | NA | −0.5 (−3.6 to 2.5) | .54 |
| Cardiology | 10.1 (9.9 to 10.3) | 8.6 (8.5 to 8.8) | 9.7 (9.5 to 9.9) | NA | NA | 0.9 (−1.8 to 3.7) | .43 |
| Urology | 17.9 (17.5 to 18.4) | 9.8 (9.5 to 10.1) | 10.2 (9.9 to 10.5) | NA | NA | 0.3 (−3.6 to 4.1) | .78 |
| Nephrology | 24.7 (24.2 to 25.3) | 9.0 (8.7 to 9.4) | 11.7 (11.3 to 12.1) | NA | NA | 1.9 (−2.7 to 6.5) | .35 |
| Dermatology | 29.0 (28.6 to 29.5) | 13.0 (12.7 to 13.3) | 11.2 (11.0 to 11.5) | NA | NA | −1.9 (−5.0 to 1.1) | .14 |
| Group mean | 13.5 (13.4 to 13.7) | 9.2 (9.1 to 9.3) | 9.4 (9.3 to 9.5) | 0.2 (−1.8 to 2.3) | .78 | 0.0 (−2.1 to 2.0) | .97 |
| Higher telehealth use | |||||||
| Pulmonology | 38.8 (38.3 to 39.3) | 15.1 (14.8 to 15.4) | 16.9 (16.6 to 17.3) | NA | NA | 1.3 (−3.7 to 6.3) | .53 |
| Endocrinology | 42.9 (42.6 to 43.3) | 13.1 (12.8 to 13.3) | 15.4 (15.2 to 15.7) | NA | NA | 2.7 (−1.7 to 7.1) | .19 |
| Gastroenterology | 49.9 (49.6 to 50.3) | 14.5 (14.3 to 14.7) | 15.5 (15.3 to 15.7) | NA | NA | 0.7 (−2.6 to 4.1) | .61 |
| Neurology | 54.8 (54.4 to 55.1) | 11.1 (10.8 to 11.3) | 13.3 (13.1 to 13.5) | NA | NA | 2.2 (−0.8 to 5.1) | .12 |
| Behavioral health | 65.6 (65.0 to 66.1) | 11.4 (11.1 to 11.7) | 18.2 (17.8 to 18.6) | NA | NA | 9.0 (−4.9 to 22.9) | .15 |
| Genetics | 73.0 (72.1 to 73.9) | 8.7 (8.2 to 9.3) | 10.0 (9.4 to 10.6) | NA | NA | 1.2 (−2.3 to 4.7) | .41 |
| Group mean | 50.2 (50.1 to 50.4) | 13.0 (12.9 to 13.1) | 15.3 (15.1 to 15.4) | 2.3 (−1.0 to 5.6) | .14 | 2.5 (−0.7 to 5.7) | .10 |
| Difference (higher telehealth − lower telehealth) | 36.7 (24.4 to 49.0) | 3.8 (0.9 to 6.8) | 5.8 (3.0 to 8.7) | 2.5 (−1.2 to 6.3) | .15 | 2.5 (−1.2 to 6.3) | .15 |
Abbreviation: NA, not applicable.
a
Prepandemic period is defined as 12 months from March 1, 2019, to February 28, 2020. Pandemic period is defined as 12 months from May 1, 2020, to April 30, 2021. No-show rates were calculated by taking the ratio of no-show visits (aggregated across medical groups contributing data for each subspecialty) to total scheduled visits (aggregated across medical groups contributing data for each subspecialty).